HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

L-type Ca(2+) channel activation regulates induction of c-fos transcription by hypoxia.

Abstract
In the present study we examined the intracellular pathways that link hypoxia to activation of c-fos gene expression. Experiments were performed on rat pheocromocytoma-12 (PC-12) cells. c-fos mRNA and promoter activities were analyzed by RT-PCR and reporter gene assays, respectively. BAPTA, a Ca(2+) chelator, inhibited c-fos mRNA and promoter activation by hypoxia. Nitrendipine, an L-type Ca(2+)-channel blocker, abolished, whereas BAY K 8644, an L-type channel agonist, enhanced c-fos activation by hypoxia. Ca(2+) currents were augmented reversibly by hypoxia, suggesting that Ca(2+) influx mediated by L-type Ca(2+) channels is essential for c-fos activation by hypoxia. We next determined downstream pathways activated by intracellular Ca(2+) concentration. Immunoblot analysis revealed Ca(2+)/calmodulin-dependent kinase II (CaMKII) protein in PC-12 cells and revealed that hypoxia increased the enzyme activity. KN-93, a CaMK inhibitor, blocked CaMKII activation and c-fos promoter stimulation by hypoxia. Ectopic expression of an active mutant of CaMKII (pCaMKII290) stimulated c-fos promoter activity under normoxia. Hypoxia increased phosphorylation of CREB at the serine residue 133 (Ser-133), and KN-93 attenuated this effect. Point mutations at the Ca(2+)/cAMP-responsive cis-element (Ca/CRE) attenuated, whereas point mutations in the serum-responsive cis-element (SRE) abolished transcriptional activation of c-fos by hypoxia. These results demonstrate that c-fos activation by hypoxia involves CaMK activation and CREB phosphorylation at Ser-133 and requires Ca/CRE and SRE. These observations demonstrate that Ca(2+)-dependent signaling pathways play a crucial role in induction of c-fos gene expression, which may underlie long-term adaptive responses to hypoxia.
AuthorsD R Premkumar, R R Mishra, J L Overholt, M S Simonson, N S Cherniack, N R Prabhakar
JournalJournal of applied physiology (Bethesda, Md. : 1985) (J Appl Physiol (1985)) Vol. 88 Issue 5 Pg. 1898-906 (May 2000) ISSN: 8750-7587 [Print] United States
PMID10797155 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Calcium Channel Agonists
  • Calcium Channel Blockers
  • Calcium Channels, L-Type
  • Chelating Agents
  • Cyclic AMP Response Element-Binding Protein
  • Enzyme Inhibitors
  • Proto-Oncogene Proteins c-fos
  • RNA, Messenger
  • Egtazic Acid
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2
  • Calcium-Calmodulin-Dependent Protein Kinases
  • 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid
Topics
  • Animals
  • Calcium Channel Agonists (pharmacology)
  • Calcium Channel Blockers (pharmacology)
  • Calcium Channels, L-Type (physiology)
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2
  • Calcium-Calmodulin-Dependent Protein Kinases (antagonists & inhibitors)
  • Chelating Agents (pharmacology)
  • Cyclic AMP Response Element-Binding Protein (metabolism)
  • Egtazic Acid (analogs & derivatives, pharmacology)
  • Enzyme Inhibitors (pharmacology)
  • Gene Expression Regulation (physiology)
  • Hypoxia (genetics, physiopathology)
  • PC12 Cells
  • Phosphorylation
  • Point Mutation (physiology)
  • Promoter Regions, Genetic (physiology)
  • Proto-Oncogene Proteins c-fos (genetics)
  • RNA, Messenger (metabolism)
  • Rats
  • Transcription, Genetic (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: